18 October 2022 · A patient safety alert highlighted the risks of giving inappropriate doses of naloxone. We guide on using appropriate intravenous doses in the medical setting.
14 October 2022 · Constipation in people taking clozapine can be fatal. Guidance on preventing and managing constipation in these individuals is described.
26 September 2022 · All calcium channel blockers may cause peripheral oedema. There are different treatment options and the incidence can be affected by different factors.
21 September 2022 · Safety risks and mitigation strategies are described to reduce the risk of errors with intravenous paracetamol in neonates, infants, and children.
7 September 2022 · Healthcare professionals who use vitamin D should be aware of the risks of toxicity and safe practice principles which may prevent patient harm
7 September 2022 · Healthcare professionals involved in the use of metolazone need to be aware of the differences between licensed and unlicensed products to ensure safe care.
11 August 2022 · Morphine sulfate products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
11 August 2022 · Phenol products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
11 August 2022 · Ropivacaine products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
11 August 2022 · Hydrocortisone products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration